Wide-complex tachycardia: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Background== | |||
Consider hyperkalemia & dig OD! | |||
==TREATMENT (WIDE)== | ==TREATMENT (WIDE)== | ||
#Pulseless --> shock (sync 360J) | |||
#Unstable --> shock (sync 100J -200J monophasic, or 50-100J biphasic) | |||
#Stable | |||
##Regular^ | |||
###Tx as presum V.Tach | |||
####Amiodarone (150mg over 10min, then 1mg/min gtt x 6hrs) | |||
####Procainamide (15-18mg/kg over 30 min) | |||
###May cardiovert | |||
###See Refractory | |||
##Irregular^^ | |||
###HR <200 | |||
####Presum aberrant a. fib^^ | |||
###HR 200-250 | |||
###HR >250 | |||
==^DDx Regular== | |||
#V. tach | |||
#Tachycardia + BBB | |||
#Tachycardia + rate related BBB | |||
#Hyperkalemia, meds (e.g. procainamide, flecainide, TCAs, dig) | |||
#Pacemaker | |||
#Tachycardia + Accessory pathway | |||
==V-TACH (BRUGADA CRITERIA)== | ==V-TACH (BRUGADA CRITERIA)== | ||
Regular rhythms only | |||
Any 1 of the following = Vtach: | Any 1 of the following = Vtach: | ||
| Line 48: | Line 33: | ||
(matters only if stable, for drug choice) | (matters only if stable, for drug choice) | ||
#Absence of RS complex in all precordial leads | |||
#RS >100ms (>2.5mm) in any precordial | |||
#AV dissociation (fusion beats) | |||
#Morphology criteria for VT in V1 or V6 (clear R/L-BB pattern) | |||
==^^DDX Irregular== | |||
#A.fib + BBB | |||
#A.fib + rate related BBB | |||
##(QRS widest with shortest R-R) | |||
#V. tach (see Brugada Criteria) | |||
#A.fib + hyperkalemia or meds | |||
#Accessory pathway*** | |||
#The danger = A.fib + aberrant pathway (in WPW) | |||
##do not use adenosine, beta blockers, dilt, or dig | |||
##changing morphology of QRS = inc poss | |||
##consider procainamide or ibutilide (amiodarone?) | |||
##shock if becomes unstable | |||
==REFRACTORY V-TACH== | ==REFRACTORY V-TACH== | ||
#Overdrive pacing | |||
#Lidocaine | |||
Overdrive pacing | #Magnesium | ||
#Electrolytes | |||
Lidocaine | #?dilantin | ||
Magnesium | |||
Electrolytes | |||
?dilantin | |||
==See also== | ==See also== | ||
Cards: V TACH Vs. Aberrant SVT | Cards: V TACH Vs. Aberrant SVT | ||
==Source == | ==Source == | ||
8/07 DONALDSON (adapted from EM, Rosen) | 8/07 DONALDSON (adapted from EM, Rosen) | ||
[[Category:Cards]] | [[Category:Cards]] | ||
Revision as of 17:53, 12 March 2011
Background
Consider hyperkalemia & dig OD!
TREATMENT (WIDE)
- Pulseless --> shock (sync 360J)
- Unstable --> shock (sync 100J -200J monophasic, or 50-100J biphasic)
- Stable
- Regular^
- Tx as presum V.Tach
- Amiodarone (150mg over 10min, then 1mg/min gtt x 6hrs)
- Procainamide (15-18mg/kg over 30 min)
- May cardiovert
- See Refractory
- Tx as presum V.Tach
- Irregular^^
- HR <200
- Presum aberrant a. fib^^
- HR 200-250
- HR >250
- HR <200
- Regular^
^DDx Regular
- V. tach
- Tachycardia + BBB
- Tachycardia + rate related BBB
- Hyperkalemia, meds (e.g. procainamide, flecainide, TCAs, dig)
- Pacemaker
- Tachycardia + Accessory pathway
V-TACH (BRUGADA CRITERIA)
Regular rhythms only
Any 1 of the following = Vtach:
(matters only if stable, for drug choice)
- Absence of RS complex in all precordial leads
- RS >100ms (>2.5mm) in any precordial
- AV dissociation (fusion beats)
- Morphology criteria for VT in V1 or V6 (clear R/L-BB pattern)
^^DDX Irregular
- A.fib + BBB
- A.fib + rate related BBB
- (QRS widest with shortest R-R)
- V. tach (see Brugada Criteria)
- A.fib + hyperkalemia or meds
- Accessory pathway***
- The danger = A.fib + aberrant pathway (in WPW)
- do not use adenosine, beta blockers, dilt, or dig
- changing morphology of QRS = inc poss
- consider procainamide or ibutilide (amiodarone?)
- shock if becomes unstable
REFRACTORY V-TACH
- Overdrive pacing
- Lidocaine
- Magnesium
- Electrolytes
- ?dilantin
See also
Cards: V TACH Vs. Aberrant SVT
Source
8/07 DONALDSON (adapted from EM, Rosen)
